COVID-19 UPDATE: Firm Operations Continue Uninterrupted. Free Virtual Consultations Available. Click Here.
ACCIDENT NEWS

Pedestrian Killed in Crash on Highway 52 Near Mast Boulevard


2 Vehicles, Pedestrian Collide in Fatal Santee Accident

Santee, CA (June 27, 2020) – A pedestrian was killed in a crash in Santee. The fatal accident occurred on the morning of June 27 on Highway 52.

Two vehicles and a pedestrian were involved in a crash on eastbound Highway 52, near Mast Boulevard. It is unknown how the accident occurred. The pedestrian was killed in the crash.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Santee

#92071


May 6, 2020

Alvino San Pedro Dominguez Killed in Accident on S. Woodrow Avenue

Man Was Cutting Palm Trees in Fatal Fresno Accident...


August 3, 2020

Man Killed in Crash at Senter Road and Needles Drive

Vehicle Hits Tree in Fatal San Jose Accident ...


June 29, 2020

1 Killed, 2 Injured in Crash on Highway 94 Near Community Building Road

2 Vehicles Collide Head-on in Fatal Dulzura Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


September 21, 2020

Lawsuit: ‘Tens Of Thousands’ Of Elmiron Patients At Risk For Vision Loss

A lawsuit filed on September 8 claims that “tens of thousands” of Elmiron patients were put at risk and hurt as a result of Janssen Pharmaceuticals’ conduct.


September 21, 2020

Lawsuit Claims Gilead Made ‘Unlawful’ Payment Over Truvada Competition

A lawsuit filed on Thursday claims that Gilead made an “unlawful” payment to Cipla in exchange for Cipla’s agreement to not compete against Truvada. The complaint states the payment “likely” came in the form of a license to produce Atripla, a license to produce Hepatitis C drugs in India or both.